To further identify the subtype of breast cancer, such as TNBC, serum apolipoprotein C-I (apoC-I) was identified and proven to be upregulated in TNBC compared with both non-TNBC and the controls, including benign breast disease and healthy subjects. Here, APOC1 is linked to breast fibrocystic disease.